Metastatic urachal cancer responding to FOLFOX chemotherapy

Canadian Journal of Urology

Volumn 17, Issue 2, 2010, Pages 5120-5123

  Tran, Ben ^a   McKendrick, Joe ^a  

^a BOX HILL HOSPITAL   (Australia)

Author keywords

Bladder adenocarcinoma; Chemotherapy; Urachal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLFOX PROTOCOL; FOLINIC ACID; PLATINUM COMPLEX;

ADENOCARCINOMA; ARTICLE; BLADDER TUMOR; CASE REPORT; CYSTECTOMY; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; THYROID TUMOR; TREATMENT OUTCOME; URACHUS;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYSTECTOMY; FLUOROURACIL; HUMANS; LEUCOVORIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; THYROID NEOPLASMS; TREATMENT OUTCOME; URACHUS; URINARY BLADDER NEOPLASMS;

EID: 77956202294     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ashley RA, Inman BA, Routh JC, Krambeck AE, Siddiqui SA, Mynderse LA, Gettman MT, Blute ML. Urachal anomalies: a longitudinal study of urachal remnants in children and adults. J Urol 2007;178(4 Pt 2):1615-1618.
2. Siefker-Radtke A. Urachal carcinoma: surgical and chemotherapy options. Expert Rev Anticancer Ther 2008;6(12):1715-1721.
3. Yu JS, Kim, KW, Lee HJ, Lee YJ, Yoon CS, Kim MJ. Urachal remnant diseases: spectrum of CT and US fi ndings. Radiographics 2001;21(2):451-461.
4. Molina JR, Quevedo JF, Furth AF, Richardson RL, Zincke H, Burch PA. Predictors of survival from urachal cancer. Cancer 2007;110(11):2434-2440.
5. Siefker-Radtke AO, Gee J, Shen Y, Wen S, Dallani D, Millikan RE, Pisters LL. Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience. J Urol 2003;169(4): 1295-1298.
6. Paras FA, MacLennan GT. Urachal adenocarcinoma. J Urol 2008; 180(2):720.
7. Mohile SG, Schleicher L, Petrylak DP. Treatment of metastatic urachal carcinoma in an elderly woman. Nat Clin Pract Oncol 2008;5(1):55-58.
8. Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 2006; 107(4):712-720.
9. Wright JL, Porter MP, Li, CI, Lange PH, Lin DW. Differences in survival among patients with urachal and non-urachal adenocarcinomas of the bladder. Cancer 2006;107(4):721-728.
10. Herr HW, Bochner BH, Sharp D, Dalbagni G, Reuter VE. Urachal carcinoma: contemporary surgical outcomes. J Urol 2007; 178(1):74-78.
11. Tazi E, Layla I, Tazi MF, Ahallal Y, M'Rabti H, Errihani H. Treatment of metastatic urachal cancer in a young woman: a case report. Cases J 2009;2:9145.